Marksans Pharma Limited ( MARKSANS.NS) - Stock Earnings

MARKSANS.NS Quarterly earnings

DateEarningsRevenue
2026Q1 1.5 billion INR 8.6 billion INR
2026Q2 1.6 billion INR 8.4 billion INR
2026Q3 1.4 billion INR 9.4 billion INR

MARKSANS.NS Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2024 3.1 billion INR 21.8 billion INR
2025 3.8 billion INR 26.2 billion INR
2026 4.2 billion INR 29.5 billion INR
2026 Est. — —

MARKSANS.NS

Price: ₹291.15

52 week price:
154.57
350.95

Forward Dividend Yield: 0.31%

Payout Ratio: 8.16%

Payout Ratio Range:
-112.88%
995.12%

Dividend Per Share: 0.90 INR

Earnings Per Share: 12.35 INR

P/E Ratio: 25

Exchange: NSI

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 139.9 billion

Average Dividend Frequency: 1

Years Paying Dividends: 13

Links: